AgingResearch.NewsJoin free

Cancer Research UK

CompanyUnited KingdomFounded 2002

RORWikidata

Cancer Research UK develops one asset, preclinical (ORIC-259 in cancer). Mostly small molecule acting on CIP2A; based in the United Kingdom, founded in 2002.

1
Asset
Furthest stage
Preclinical
18
Trials
1
Signal

Pipeline

1

  • ORIC-259

    Small molecule mRNA degrader targeting CIP2A

    Preclinical, Small molecule, CIP2A, cancer, Partner

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials73
  • Signals1
  • Integrity notices10
  • Similar companies6

Papers

Intelligence